Barriers to Healthcare Utilization and Adherence to Medications among People Living with Parkinson’s Disease in Senegal
Objective: To explore the barriers to healthcare utilization and adherence to medications among people living with Parkinson’s disease in Senegal, and propose context-informed strategies to…A Systematic Review on the Reliability of Data-Driven Parkinson’s Disease Subtypes
Objective: To systematically evaluate data-driven Parkinson’s disease (PD) subtyping studies, focusing on their methodological quality and clinical applicability. Background: The heterogeneity of PD suggests distinct…Transformation of Parkinson’s care through Self-Management, Remote monitoring and Timely review (SMaRT-PD): Care Pathway Mapping with Clinical Experts
Objective: To elicit healthcare professionals’ perspectives on the introduction of a clinical decision support system (CDSS) to facilitate Parkinson’s disease care provision: impact on current…Prospective observational study on the effects of physical exercise and lifestyle modifications in patients with Parkinson’s disease
Objective: This study aimed to assess the effectiveness of physical activity, which includes all movements that increase energy expenditure, in conjunction with exercise, characterized as…A Case of SGCE Myoclonus-Dystonia diagnosed in a 70-Year-Old Male
Objective: N/A Background: SGCE myoclonus-dystonia (SGCE-M-D) is a movement disorder characterized by myoclonus and dystonia, primarily affecting the neck, trunk, and upper limbs. Patients may…Artificial Intelligence for Understanding Parkinson Disease State and Patient Stratification Using CSF Proteomics
Objective: The objective of this research is to employ an Artificial Intelligence (AI) approaches to identify patient status and disease states in neurodegenerative diseases (NDDs),…Parkinson’s Progression Markers Initiative (PPMI): A Biomarker Engine for Therapeutic Development for PD and Related Synucleinopathies
Objective: PPMI is a longitudinal, observational study investigating clinical, imaging, genetic and biofluid biomarkers to accelerate therapeutic development for Parkinson’s disease (PD) and related synucleinopathies…Key components for safer mobility behaviour assessment and intervention for people with Parkinson’s disease: A modified Delphi study
Objective: To develop a consensus-based summary of key components that people with lived experience, clinicians and researchers find important to include in an assessment tool…Challenges in the Diagnosis and Management of Functional Movement Disorders in a Developing Nation: Insights from the Philippines
Objective: To systematically analyze patient data to explore the clinical phenotypes, risk factors, management, and outcomes among patients with functional movement disorders (FMD) in the…Dystonia in Cameroon: Clinical characteristic and treatment patterns
Objective: To describe the clinical characteristics and treatment patterns of dystonia in a cohort of Cameroonian patients. Background: Dystonia is a complex and heterogeneous movement…
- « Previous Page
- 1
- …
- 291
- 292
- 293
- 294
- 295
- …
- 1942
- Next Page »